- Report
- June 2026
- 200 Pages
Global
From €2754EUR$2,990USD£2,322GBP
- Report
- October 2025
- 120 Pages
Global
From €5480EUR$5,950USD£4,621GBP
- Report
- February 2026
- 250 Pages
Global
From €4136EUR$4,490USD£3,487GBP
- Report
- September 2026
- 193 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- September 2026
- 194 Pages
Global
From €3265EUR$3,545USD£2,753GBP
€3628EUR$3,939USD£3,059GBP
- Report
- October 2026
- 152 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- October 2026
- 732 Pages
Global
From €5388EUR$5,850USD£4,543GBP
- Report
- August 2026
- 183 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- August 2026
- 180 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- August 2026
- 182 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- August 2026
- 182 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- August 2026
- 181 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- May 2026
- 148 Pages
Global
From €3638EUR$3,950USD£3,067GBP
- Report
- November 2025
- 120 Pages
Middle East
From €5480EUR$5,950USD£4,621GBP
- Report
- March 2021
- 216 Pages
Global
From €2533EUR$2,750USD£2,136GBP
- Report
- November 2024
- 150 Pages
Global
From €5480EUR$5,950USD£4,621GBP
- Report
- July 2024
- 70 Pages
Europe
From €2717EUR$2,950USD£2,291GBP
- Report
- February 2024
- 255 Pages
Global
From €4559EUR$4,950USD£3,844GBP
- Report
- May 2025
- 115 Pages
Global
From €4375EUR$4,750USD£3,689GBP
- Report
- July 2024
- 120 Pages
Global
From €4375EUR$4,750USD£3,689GBP

Molecular biomarkers are molecules that can be used to identify and measure biological processes, such as disease states or drug responses. They are used in a variety of applications, including diagnostics, drug development, and personalized medicine. Molecular biomarkers are typically proteins, nucleic acids, or metabolites that can be measured in a variety of biological samples, such as blood, urine, or tissue.
The molecular biomarker market is a rapidly growing segment of the larger biomarker market. It is driven by advances in technology, such as next-generation sequencing and mass spectrometry, which have enabled the identification and quantification of molecular biomarkers with greater accuracy and sensitivity. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are driving the demand for molecular biomarkers.
Some companies in the molecular biomarker market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more